What is the role of Brentuximab vedotin in the treatment of advanced-stage Hodgkin's lymphoma?
Label:chem
Topic
Brentuximab vedotin is an antibody-drug conjugate that targets CD30, a protein expressed on Hodgkin lymphoma cells. It delivers a cytotoxic agent directly to cancer cells, minimizing damage to healthy tissues.
Answer
Brentuximab vedotin enhances the efficacy of chemotherapy regimens by targeting cancer cells more precisely and improving progression-free survival (PFS) and overall survival (OS) compared to traditional ABVD therapy.
Return to Home
Chemical List
Knowledge you may be interested in